DPIIT recognised startup Government of India
Startup India
Sapigen Biologix Private Limited
Sapigen Biologix Private Limited - research & development in Bhubaneswar, Odisha, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹3.53 Cr
▲ 87% YoY
Net loss · FY 2025
₹120.35 Cr
Latest filing
EBITDA · FY 2025
-₹56.92 Cr
Latest filing
Authorised capital
₹830 Cr
Registered with MCA
Paid-up capital
₹824 Cr
Issued & subscribed
Open charges
₹322.77 Cr
Secured borrowings
Company age
6 yrs
Est. 2020
Employees · EPFO
107
Provident fund records
About Sapigen Biologix Private Limited
Data last updated:
Sapigen Biologix Private Limited is a private limited company based in Bhubaneswar, Odisha, India, a subsidiary of Biovet Private Limited and recognised as a startup by DPIIT. It operates in the scientific research segment of the research and development sector. It was incorporated on 17 October 2020 and has been in existence for over 6 years.
Its director Krishna Murthy Ella and family are #342 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U73100OD2020PTC046324. Its GSTIN is 21ABECS6949L1ZX (Odisha). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹830 Cr and a paid-up capital of ₹824 Cr. It is led by directors including Raches Virendradev Ella (Managing Director) and Jalachari Ella.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 7 Odisha Biotech Park, Odisha.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.53 Cr, a growth of 87% compared to the previous year. For the same year it recorded a net loss of ₹120.35 Cr and EBITDA of -₹56.92 Cr.
The company has about 107 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹322.77 Cr on record. The company has 7 deals on record (3 rights issues, 3 funding rounds, 1 acquisition), with disclosed funding of ₹207.31 Cr; the latest was in October 2022. Its 3 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 1 smaller; the largest is Plus India Formulation Private Limited with revenue of ₹3.55 Cr.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U73100OD2020PTC046324
Registration Number 046324
Incorporation Date 17 October 2020
ROC Cuttack
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2024
Parent Company Biovet Private Limited
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
CIN history
Sapigen Biologix has one previous CIN (Corporate Identification Number): U73100TG2020PTC144962. The current CIN is U73100OD2020PTC046324, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U73100OD2020PTC046324 | Current |
| U73100TG2020PTC144962 | Previous |
Key People
Raches Virendradev Ella Managing Director Jalachari Ella Director Krishna Murthy Ella Director Recognitions & Rankings of Sapigen Biologix
India's Richest People 2026 edition · 1 director · Source: Hurun India
- #342 Krishna Murthy Ella & family ₹11,000 Cr
Contact details
Sapigen Biologix Private Limited's registered office is in Bhubaneswar, Odisha.
- Registered AddressPlot No. B1/24 And Itbt 1/7 Odisha Biotech Park, Daspur Road Mauza, Bhubaneswar, Odisha, India – 751003
- IndustryResearch & Development, Science Research
Comprehensive company report
Sapigen Biologix Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Sapigen Biologix is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sapigen Biologix Private Limited, buy the company report.
Financials of Sapigen Biologix Private Limited
FY 2024 filings availableSapigen Biologix Private Limited reported revenue of ₹3.53 Cr (up 87% YoY) for FY 2025.
Revenue · FY 2025
₹3.53 Cr ▲ 87%
Net loss · FY 2025
₹120.35 Cr
EBITDA · FY 2025
-₹56.92 Cr
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 87%
Revenue rose 87% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹56.92 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹120.35 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sapigen Biologix Private Limited, buy the company report.
Board of directors of Sapigen Biologix Private Limited
Sapigen Biologix has 6 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jalachari Ella Also directs: Skegen Asset Management LLP, Innova Agri Bio Park Private Limited, Ella Fresh Private Limited and 4 more | Director | 18 Mar 2021 | 5 Years 7 Months | Current |
| Krishna Murthy Ella Also directs: Skegen Asset Management LLP, Probiomics Private Limited, Nucelion Therapeutics Private Limited and 4 more | Director | 17 Oct 2020 | 6 Years 0 Months | Current |
| Duruvasan Ramachandra | Director | 28 Mar 2025 | 1 Years 7 Months | Current |
| Raches Virendradev Ella Also directs: Probiomics Private Limited, Nucelion Therapeutics Private Limited, Chiron Behring Vaccines Private Limited and 4 more | Managing Director | 17 Oct 2020 | 6 Years 0 Months | Current |
| Sai Prasad Devarajulu Also directs: Bharat Biotech International Limited, Skebio Infra LLP, Chiron Behring Vaccines Private Limited and 4 more | Director | 27 Oct 2025 | 1 Years 0 Months | Current |
| Melappati Chakravarthy | Director | 20 Feb 2023 | 3 Years 8 Months | Current |
Peer comparison
Sapigen Biologix Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Plus India Formulation Private Limited | ₹3.55 Cr (FY 2025) | 5.0% | Hyderabad, Telangana, India | |||
| Vivin Instruments Private Limited | ₹3.53 Cr (FY 2020) | -58.0% | Mumbai, Maharashtra, India | |||
| Sapigen Biologix Private Limitedthis company | ₹3.53 Cr (FY 2025) | -₹120.35 Cr | 87.0% | Bhubaneswar, Odisha, India | ||
| Generic Crop Sciences Private Limited | ₹3.52 Cr (FY 2025) | -2.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Sapigen Biologix Private Limited, buy the company report.
Charges & borrowings
Open charges
₹322.77 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Mar 2022 | 100552174 | Others | ₹122.77 Cr | Open | |
| 27 Dec 2021 | 100536551 | State Bank of India | ₹200 Cr | Open |
To see the full charge records of Sapigen Biologix Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Sapigen Biologix Private Limited has 7 deals on record (3 rights issues, 3 funding rounds, 1 acquisition), with disclosed funding of ₹207.31 Cr; the latest was in October 2022.
Total deals
7
Rights issues
3
Funding rounds
3
Acquisition
1
Disclosed funding
₹207.31 Cr
Deals on record (4 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2022 | Acquisition | Undisclosed | Buyer: an individual Seller: Biovet Private Limited |
| May 2022 | Rights issue | ₹14.2 Cr | Investors: Biovet Private Limited |
| Mar 2021 | Rights issue | ₹15 Cr | Investors: Biovet Private Limited |
| Dec 2020 | Rights issue | ₹2.49 Cr | Investors: Biovet Private Limited , an individual |
To see the full deal history of Sapigen Biologix Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Sapigen Biologix Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sapigen Biologix Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sapigen Biologix has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 21ABECS6949L1ZX | Odisha | Active | 09 Nov 2020 |
| 36ABECS6949L1ZM | Telangana | Active | 01 Nov 2021 |
To see the full GST registrations and return filing status of Sapigen Biologix Private Limited, buy the company report.
Recent activity
Sapigen Biologix Private Limited has 9 board changes on record since 2020: 6 appointments and 3 cessations. The latest: Sai Prasad Devarajulu was appointed as Director on 27 Oct 2025.
Appointed
Sai Prasad Devarajulu was appointed as Director.
AGM
Sapigen Biologix Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Appointed
Duruvasan Ramachandra was appointed as Director.
Ceased
Raches Virendradev Ella ceased to be Director.
Filing
Sapigen Biologix Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Cuttack.
Charges
A charge with Others of Rs. 122.77 Cr registered on 26 Mar 2022 with Charge ID 100552174 was modified on 17 Nov 2023.
Ceased
Melappati Chakravarthy ceased to be Additional Director.
Appointed
Melappati Chakravarthy was appointed as Director.
Charges
A charge with State Bank Of India of Rs. 200.00 Cr registered on 27 Dec 2021 with Charge ID 100536551 was modified on 18 May 2022.
Charges
A charge with Others amounted to Rs. 122.77 Cr with Charge ID 100552174 was registered on 26 Mar 2022.
Charges
A charge with State Bank Of India amounted to Rs. 200.00 Cr with Charge ID 100536551 was registered on 27 Dec 2021.
Ceased
Jalachari Ella ceased to be Additional Director.
4 earlier events are in the company report.
Frequently asked questions
Sapigen Biologix is an active private limited company based in Bhubaneswar, Odisha, India. The company works in science research, within the research and development industry. It was incorporated on 17 October 2020 (6+ years old) and is registered under CIN U73100OD2020PTC046324.
Sapigen Biologix has 6 current directors:
- Raches Virendradev Ella - Managing Director
- Jalachari Ella - Director
- Krishna Murthy Ella - Director
- Duruvasan Ramachandra - Director
- Sai Prasad Devarajulu - Director
- Melappati Chakravarthy - Director
The latest financial statements of Sapigen Biologix on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Sapigen Biologix is 21ABECS6949L1ZX, registered in Odisha. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 36ABECS6949L1ZM (Telangana).
The CIN (Corporate Identification Number) of Sapigen Biologix is U73100OD2020PTC046324. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sapigen Biologix was incorporated on 17 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Cuttack.
Sapigen Biologix has 7 deals on record (3 rights issues, 3 funding rounds, 1 acquisition), with disclosed funding of ₹207.31 Cr; the latest was in October 2022.
The peers of Sapigen Biologix by revenue are Plus India Formulation Private Limited, Vivin Instruments Private Limited, Generic Crop Sciences Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sai Prasad Devarajulu was appointed as Director on 27 Oct 2025. Duruvasan Ramachandra was appointed as Director on 28 Mar 2025. Raches Virendradev Ella ceased to be Director on 09 Apr 2024. Sapigen Biologix has 9 board changes on record in total.
Yes, Sapigen Biologix is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Sapigen Biologix is at Plot No. B124 And Itbt 17 Odisha Biotech Park, Daspur Road Mauza, Bhubaneswar, Odisha, India – 751003.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages